Cutler Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2453 |
|
|
2022
Q1 | – | Sell |
-8,623
| Closed | -$95K | – | 2547 |
|
|
2021
Q4 | $95K | Buy |
+8,623
| New | +$95K | ﹤0.01% | 950 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2696 |
|
|
2021
Q2 | – | Sell |
-1,500
| Closed | -$30K | – | 2687 |
|
|
2021
Q1 | $30K | Buy |
+1,500
| New | +$30K | ﹤0.01% | 1336 |
|
|
2020
Q2 | – | Sell |
-1,000
| Closed | -$23K | – | 2084 |
|
|
2020
Q1 | $23K | Buy |
+1,000
| New | +$23K | ﹤0.01% | 961 |
|
|
2019
Q4 | – | Sell |
-389
| Closed | -$7K | – | 2114 |
|
|
2019
Q3 | $7K | Sell |
389
-17,257
| -98% | -$311K | ﹤0.01% | 1242 |
|
|
2019
Q2 | $288K | Buy |
17,646
+9,146
| +108% | +$149K | 0.03% | 369 |
|
|
2019
Q1 | $192K | Buy |
+8,500
| New | +$192K | 0.02% | 458 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2155 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 2239 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 2441 |
|